Wrinkle Clinical Trial
Official title:
The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation: A Split Face Comparison
NCT number | NCT04128046 |
Other study ID # | 12698 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 3, 2018 |
Est. completion date | June 1, 2019 |
Verified date | October 2019 |
Source | New York Medical College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Platelet-rich fibrin matrix (PRFM) is made from platelets that are extracted from a patient's blood, and many plastic surgeons and dermatologists have used it to fill in wrinkles and lines on the face. Both patients and doctors have observed that it gives extra volume in these areas and improves overall appearance. However, there is no research that shows how PRFM affects skin quality, such as pores, spots, red areas, and texture. The aim of this study is to determine whether PRFM has a role in rejuvenating facial skin.
Status | Completed |
Enrollment | 30 |
Est. completion date | June 1, 2019 |
Est. primary completion date | May 28, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults 18 years of age and older who had a dermatological concern, specifically, conspicuous spots, pores, rhytids, uneven texture, or red or brown discoloration, and a VISIA complexion analysis score greater than 10 - Agreed to continue any contraceptive hormonal therapy for duration of the study - Agreed to not initiate the use of hormonal therapy during the study - Agreed to not undergo any facial procedures or treatments, including injections and fillers, lasers, peels, and topical therapies, during the duration of the study - Agreed to adhere to a standardized skin care regimen throughout the duration of the study consisting of the use of a single cleanser and moisturizer twice a day - Agreed to refrain from excessive sun exposure/tanning Exclusion Criteria: - History of skin/connective tissue disorders - History of immunosuppressive therapy or radiotherapy - Participation in facial procedures, such as injections, lasers, peels, and dermabrasion, in the last six months - Use of topical/prescription acne medications in the last three months - Current smokers or prior smokers who quit fewer than 10 years ago |
Country | Name | City | State |
---|---|---|---|
United States | New York Medical College | Valhalla | New York |
Lead Sponsor | Collaborator |
---|---|
New York Medical College |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in VISIA skin score | Difference between pre- and post-treatment VISIA analysis scores for skin parameters of spots, wrinkles, texture, and pores | Skin analysis performed at initial visit, at 6 weeks, and at 12 weeks following initial treatment | |
Secondary | Change in Wrinkle Severity Rating Scale | Difference between pre- and post-treatment quantitative grading of nasolabial folds for each group. Graded from 1 through 5, with 5 representing the worst score | Rating occurred at initial visit, at 6 weeks, and at 12 weeks following initial treatment | |
Secondary | Skin Rejuvenation Outcomes Evaluation (SROE) | Patient-reported outcome measure validated for skin resurfacing techniques. Each item is rated on a 0-4 scale. The final score is computed by dividing the total score for the instrument by 24 and multiplying by 100, giving a range of 0-100. The difference in the change in SROE score for each cohort was calculated. | Evaluation distributed at initial visit, at 6 weeks, and at 12 weeks following treatment. | |
Secondary | VISIA Outcomes Questionnaire | Evaluation targeted specifically at identifying changes in the skin parameters analyzed by VISIA. Each item is rated on a 0-4 scale. The final score is computed by dividing the total score for the instrument by 24 and multiplying by 100, giving a range of 0-100. The difference in the change in VISIA outcomes score for each cohort was calculated. | Evaluation distributed at initial visit, at 6 weeks, and at 12 weeks following treatment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05098912 -
Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction
|
N/A | |
Completed |
NCT05271136 -
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
|
N/A | |
Completed |
NCT05096247 -
Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
|
N/A | |
Completed |
NCT05097157 -
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
|
N/A | |
Active, not recruiting |
NCT04727099 -
Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™
|
N/A | |
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Not yet recruiting |
NCT05524779 -
BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement
|
N/A | |
Completed |
NCT05514782 -
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
|
N/A | |
Completed |
NCT06123572 -
A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel
|
N/A | |
Completed |
NCT04911374 -
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
|
N/A | |
Recruiting |
NCT04989361 -
Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles.
|
N/A | |
Recruiting |
NCT04540900 -
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
|
Phase 1 | |
Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
Recruiting |
NCT06074276 -
The Effects of Almond on Facial Skin Collagen and Wrinkles
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Active, not recruiting |
NCT06219278 -
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
|
N/A | |
Active, not recruiting |
NCT06192550 -
Functional Usability and Feasibility Testing of the Profound Matrix™ System
|
N/A | |
Completed |
NCT04650620 -
Study to Evaluate the Performance and Safety of the Medical Device Plenhyage®
|
N/A | |
Completed |
NCT03729700 -
The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome
|
N/A | |
Completed |
NCT05102617 -
Post Market Usability Evaluation Of The PicoSure Pro Device
|
N/A |